PT938326E - Fosfopeptidos de sintese para o tratamento de doencas dos ossos - Google Patents

Fosfopeptidos de sintese para o tratamento de doencas dos ossos

Info

Publication number
PT938326E
PT938326E PT97932409T PT97932409T PT938326E PT 938326 E PT938326 E PT 938326E PT 97932409 T PT97932409 T PT 97932409T PT 97932409 T PT97932409 T PT 97932409T PT 938326 E PT938326 E PT 938326E
Authority
PT
Portugal
Prior art keywords
phosphopepides
synthese
treatment
bone diseases
phosphopeptides
Prior art date
Application number
PT97932409T
Other languages
English (en)
Inventor
Akira Otaka
Yoshinari Kumagai
Original Assignee
Acologix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acologix Inc filed Critical Acologix Inc
Publication of PT938326E publication Critical patent/PT938326E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT97932409T 1996-07-03 1997-06-30 Fosfopeptidos de sintese para o tratamento de doencas dos ossos PT938326E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/675,031 US5837674A (en) 1996-07-03 1996-07-03 Phosphopeptides and methods of treating bone diseases

Publications (1)

Publication Number Publication Date
PT938326E true PT938326E (pt) 2004-11-30

Family

ID=24708791

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97932409T PT938326E (pt) 1996-07-03 1997-06-30 Fosfopeptidos de sintese para o tratamento de doencas dos ossos

Country Status (11)

Country Link
US (2) US5837674A (pt)
EP (1) EP0938326B1 (pt)
JP (2) JP2001503452A (pt)
AT (1) ATE275961T1 (pt)
AU (1) AU727675B2 (pt)
CA (1) CA2258661C (pt)
DE (1) DE69730725T2 (pt)
DK (1) DK0938326T3 (pt)
ES (1) ES2224260T3 (pt)
PT (1) PT938326E (pt)
WO (1) WO1998000156A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
US20030118572A1 (en) * 1997-12-29 2003-06-26 Novozymes A/S Modified enzymes
DE69935220T2 (de) * 1998-05-18 2007-11-15 University College London Von menschlichem tumor stammendes polypeptidhormon phosphatonin
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
MXPA02002315A (es) * 1999-09-02 2004-07-16 Big Bear Bio Inc Metodos y composiciones para reducir los niveles de fosfato en suero.
EP1313440B1 (en) * 2000-08-16 2008-07-16 ACOLOGIX, Inc. Dental products comprising bone growth enhancing peptide
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
AU8689201A (en) 2000-08-29 2002-03-13 Osteonet Com Inc Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) * 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7660453B2 (en) * 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
EP1392818A4 (en) * 2001-04-30 2005-01-05 Hope City FOR THE TREATMENT OF CANCER DISEASES IN HUMAN CERTAIN IMMUNE RECEPTOR
US8000766B2 (en) 2001-05-25 2011-08-16 Imatx, Inc. Methods to diagnose treat and prevent bone loss
EP1504033A2 (en) * 2002-05-03 2005-02-09 Millenium Biologix Inc. Connective tissue stimulating peptides
US7840247B2 (en) * 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
US7664298B2 (en) * 2003-03-25 2010-02-16 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
US8073521B2 (en) * 2003-09-19 2011-12-06 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
CA2580726A1 (en) 2004-09-16 2006-03-30 Imaging Therapeutics, Inc. System and method of predicting future fractures
JP2008526871A (ja) * 2005-01-07 2008-07-24 アコロジックス インコーポレイティッド 歯周および歯の治療のためのペプチド製剤
US7622438B1 (en) 2005-07-18 2009-11-24 Acologix, Inc. Protein formulation for promoting hard tissue formation
EP2061376A2 (en) * 2006-09-15 2009-05-27 Imaging Therapeutics, Inc. Method and system for providing fracture/no fracture classification
EP2117578B1 (en) * 2007-01-22 2015-04-22 OrthoTrophix, Inc. A peptide composition and a method of promoting cartilage formation
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage
TWI382852B (zh) * 2009-12-22 2013-01-21 Univ Taipei Medical 一種口腔保健用磷酸鈣複合物及其製法與組合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015A (en) * 1847-03-13 Mode of producing reciprocating and latkral motions
CA1315480C (en) * 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
JPH01285158A (ja) * 1988-05-12 1989-11-16 Itochu Shiryo Kk 家禽用飼料
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases

Also Published As

Publication number Publication date
ES2224260T3 (es) 2005-03-01
EP0938326A1 (en) 1999-09-01
US6306822B1 (en) 2001-10-23
CA2258661C (en) 2002-09-10
US5837674A (en) 1998-11-17
CA2258661A1 (en) 1998-01-08
DE69730725T2 (de) 2006-02-23
WO1998000156A1 (en) 1998-01-08
DK0938326T3 (da) 2005-01-03
AU727675B2 (en) 2000-12-21
JP2004067687A (ja) 2004-03-04
EP0938326B1 (en) 2004-09-15
AU3587197A (en) 1998-01-21
DE69730725D1 (de) 2004-10-21
EP0938326A4 (en) 2002-07-03
JP2001503452A (ja) 2001-03-13
ATE275961T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
PT938326E (pt) Fosfopeptidos de sintese para o tratamento de doencas dos ossos
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ATE271393T1 (de) Zusammensetzungen zur erhöhung des hautdurchtritts von arzneistoffen unter verwendung von permeationsbeschleunigern
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
FI972793A0 (fi) Nebivololin käyttö antiaterogeenisenä aineena
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
PT946166E (pt) Utilizacao de inibidores das metaloproteinases da matriz para tratar disturbios neurologicos e promover a cicatrizacao de feridas
DE60027870D1 (de) Genetische manipulierte herpesviren zur behandlung von tumoren
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
DE69813200D1 (de) Verbesserung der wundheilung mit cm101/gbs-toxin
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
ES2180175T3 (es) Uso de una sustancia inhibidora para la mejora de la regeneracion neuronal.
BR0013416A (pt) Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturado
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
EE9600190A (et) Farmatseutiline kompositsioon viirusinfektsioonide ja võimalike kaasnevate põletike vältimiseks ja/või raviks ning nimetatud haiguste ravimeetod
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
DE59911556D1 (de) Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor
BR9612549A (pt) Método para tratamento de agressão excessiva
DE69910608D1 (de) Neue therapeutische verwendung von 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
DK8893D0 (da) Medicament for treatment or prevention of disease